YOLFTbeta
ASTERASYS Co.,Ltd

ASTERASYS Co.,Ltd

450950 · KQ · Healthcare / Medical Devices

4,995.00KRW-25.00 (-0.50%)

Price History

Full chart

Market Stats

Previous Close5,020.00
Open5,020.00
Day Range4,940.00 – 5,050.00
52-Week Range4,050.00 – 17,404.25
Volume15.43K
Market Cap239.69B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield1.66%
50-Day Avg5,504.40
200-Day Avg9,477.60

About

ASTERASYS Co.,Ltd manufactures and sells medical equipment for hospitals and skin care devices for beauty care clinics and salons in South Korea, Europe, Asia, the Middle East, Africa, North America, South America, Australia, and New Zealand. The company offers Coolfase, a monopolar RF device with direct cooling in tip; Q-facial, a skin management equipment; Liftera for facial skin lifting; Liftera2, a dual-type HIFU technology that enables combination treatments using Line and Pen-type applicators; and Futera Dots for fractional skin resurfacing. It serves healthcare, aesthetics, distribution, and IoT sectors. The company was formerly known as DAIHAN Biomedical Co., Ltd. and changed its name to ASTERASYS Co.,Ltd in January 2018. The company was founded in 2015 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOEunTaek Seo
  • Employees100
  • Headquarters66, Seongsui-ro, Seoul, South Korea, Korea
  • Websitehttps://www.asterasys.com

Leadership

  • EunTaek SeoCEO & Representative Director

Financials

Income Statement

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Total Revenue15.62B17.50B28.83B37.94B
Growth (%)-+12.04%+64.78%+31.60%
Cost of Revenue5.11B4.53B7.94B7.90B
Gross Profit10.50B12.97B20.89B30.04B
Gross Margin67.26%74.13%72.46%79.17%
Operating Expense8.72B11.42B14.23B19.65B
Operating Income1.78B1.56B6.66B10.39B
Operating Margin11.41%8.89%23.11%27.39%
EBITDA3.06B2.97B8.42B12.65B
EBITDA Margin19.59%17.00%29.21%33.33%
Net Income1.21B871.83M5.35B9.21B
Net Income Margin7.75%4.98%18.56%24.27%
R&D1.59B2.58B2.64B3.26B
R&D as % of Total Revenue10.16%14.74%9.16%8.59%
Interest Expense716.24M853.34M550.76M70.84M
Interest Expense % of Total Revenue4.59%4.88%1.91%0.19%

Balance Sheet

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Total Assets14.57B16.60B24.73B52.21B
Total Liabilities9.12B9.88B5.09B5.45B
Total Equity5.45B6.72B19.64B46.76B
Cash4.38B3.64B6.14B6.91B
Net Debt449.51M1.64B--

Cash Flow

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow3.56B1.48B4.36B4.99B
Capital Expenditure929.60M1.60B1.23B1.50B
Free Cash Flow2.63B-115.81M3.13B3.49B
Dividends Paid---3.07B
FCF to OCF73.91%-7.80%71.69%69.93%
Dividend Paid to FCF---88.00%

Earnings

Report DateMar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------
EPS Actual14.6078.3150.52101.96-25.5434.51
Surprise------
Timing------

Key Statistics & Ratios

Market Cap239.69B
Enterprise Value180.39B
Trailing P/E0.00
Forward P/E0.00
Price / Sales6.05
Price / Book4.34
Revenue (TTM)39.61B
Gross Profit (TTM)31.55B
EBITDA6.27B
Profit Margin15.36%
Operating Margin0.71%
Return on Equity14.14%
Return on Assets5.47%
Shares Outstanding37.63M
Shares Float18.52M
Dividend Yield1.66%
Dividend Rate106.00
Payout Ratio32.21%

Dividends

20252×
52.00Dec 29, 202554.00Aug 25, 2025